Schizophrenia Trial, Recruiting (NCT06286202)

Schizophrenia Trial, Recruiting NCT06286202 Sponsor: Singapore Institute of Technology Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT06286202 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with schizophrenia or schizoaffective disorder based on standard medical guidelines (DSM-5).
You have completed at least 10 years of formal schooling, with English as the main language of instruction.
You are able to hold a conversation in English and understand instructions given in English, as the program is run in English.

Who may not be able to join:

You have a known neurological condition (a disease affecting the brain or nervous system) or epilepsy.
You are unable to speak or understand English.
You have been admitted to a hospital within the past month.
Your overall daily functioning is assessed as very low by a doctor using a standard medical scoring tool called the Global Assessment of Functioning (GAF), specifically a score of 30 or below (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bhing-Leet Tan, PhD, Bhing-Leet Tan

Phone: +6598422783

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06286202

Sponsor: Singapore Institute of Technology

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: +6598422783

More information: https://clinicaltrials.gov/study/NCT06286202

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with schizophrenia or schizoaffective disorder based on standard medical guidelines (DSM-5).
You have completed at least 10 years of formal schooling, with English as the main language of instruction.
You are able to hold a conversation in English and understand instructions given in English, as the program is run in English.

Who may not be able to join:

You have a known neurological condition (a disease affecting the brain or nervous system) or epilepsy.
You are unable to speak or understand English.
You have been admitted to a hospital within the past month.
Your overall daily functioning is assessed as very low by a doctor using a standard medical scoring tool called the Global Assessment of Functioning (GAF), specifically a score of 30 or below (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Singapore Institute of Technology

Registry

ClinicalTrials.gov

Start date

6 August 2024

Est. completion

1 June 2027

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Brief Assessment of Cognition in Schizophrenia (BACS); Bell Lysaker Emotion Recognition Task (BLERT); Canadian Occupational Performance Measure (COPM); Social and Occupational Functioning Assessment Scale (SOFAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov